Tag: Type II Diabetes

Kidney disease has been recognized as a complication of type 2 diabetes mellitus (T2DM) since the 1950s, developing in approximately 35% of patients with T2DM and affecting as many as 50% of patients with diabetes through a 20 years’ duration. The prevalence of diabetic kidney disease (DKD) in the United States increased from 1988 to 2008 in proportion to the prevalence of diabetes. Among adults with diabetes, the prevalence of DKD has remained stable despite increased use of antihyperglycemic agents and renin-angiotensin-aldosterone system (RAAS) inhibitors.

Source:2018 Virtual Symposium: Management of T2DM Patients with Diabetic Kidney Disease: Effects of SGLT2 Inhibitors and GLP-1 Receptor Agonists on Disease Progression

Vitamin C supplementation is associated with improved blood glucose levels in people with type 2 diabetes, research suggests. A small Australian study, published in the journal Diabetes, Obesity and Metabolism, reports that people with type 2 diabetes who took a vitamin C tablet two times a day reduced their blood glucose spikes after meals by 36%.

Source: Vitamin C linked to reduced glucose levels in type 2 diabetes

Among adults with obesity and type 2 diabetes who underwent bariatric surgery and experienced diabetes remission at their first follow-up appointment, baseline HbA1c and excess body weight loss 1 year after surgery were independent predictors of diabetes relapse over 5 years, according to findings published in the International Journal of Obesity.

Source: Baseline HbA1c, weight loss after bariatric surgery predict type 2 diabetes relapse

Irrespective of age and weight, women with polycystic ovary syndrome (PCOS) have an increased risk for type 2 diabetes, according to a study published online Jan. 31 in Diabetes Care.

Source: Type 2 Diabetes Risk Up With PCOS Regardless of BMI

Patients with type 2 diabetes mellitus suffer from dysregulation of a plethora of cardiovascular and metabolic functions, including dysglycaemia, dyslipidaemia, arterial hypertension, obesity and a reduced cardiorespiratory fitness. Exercise training has the potential to improve many of these functions, such as insulin sensitivity, lipid profile, vascular reactivity and cardiorespiratory fitness, particularly in type 2 diabetes mellitus patients with cardiovascular comorbidities, such as patients that suffered from an acute myocardial infarction, or after a coronary intervention such as percutaneous coronary intervention or coronary artery bypass grafting.

Source: Exercise training for patients with type 2 diabetes and cardiovascular disease: What to pursue and how to do it. A Position Paper of the European Association of Preventive Cardiology (EAPC) – Hareld Kemps, Nicolle Kränkel, Marcus Dörr, Trine Moholdt, Matthias Wilhelm, Francesco Paneni, Luis Serratosa, Erik Ekker Solberg, Dominique Hansen, Martin Halle, Marco Guazzi, 2019

A new review of existing research examines the effect of the gut bacteria composition on the effectiveness of type 2 diabetes medications.

Source: Type 2 diabetes: Gut bacteria may influence drug effectiveness

A single injection combination of basal insulin glargine and lixisenatide known as iGlarLixi improves glycemic control without increasing the risk for severe hypoglycemia in older adults with type 2 diabetes, according to findings published in the Journal of Diabetes and its Complications. “We have a limited number of safe treatments for people above [age] 65 [years].

Source: Insulin glargine, lixisenatide combination safe, effective for older adults with type 2 diabetes